Arcitumomab
Arcitumomab
Arcitumomab (pronounced: ar-si-tu-mo-mab) is a monoclonal antibody used in the detection of certain types of cancer. It is a radiopharmaceutical agent that is used in immunoscintigraphy procedures.
Etymology
The name "Arcitumomab" is derived from the Latin "arcere" meaning to ward off, and "tumomab" is a common suffix for monoclonal antibodies.
Usage
Arcitumomab is used in the detection of colorectal cancer. It is administered intravenously and works by binding to a specific antigen, carcinoembryonic antigen (CEA), which is often present in high amounts in individuals with colorectal cancer.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Radiopharmaceutical: A drug that contains radioactive substances which are used to treat certain conditions or to image certain parts of the body.
- Immunoscintigraphy: A type of imaging test that uses radioactive substances to detect certain diseases in the body.
- Carcinoembryonic antigen (CEA): A protein that may be higher in individuals with certain types of cancers, including colorectal cancer.
See Also
- Monoclonal Antibodies in Oncology
- Radiopharmaceuticals in Nuclear Medicine
- Immunoscintigraphy in Diagnostic Imaging
- Carcinoembryonic Antigen in Tumor Markers
External links
- Medical encyclopedia article on Arcitumomab
- Wikipedia's article - Arcitumomab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski